In the latest trading session, 4.24 million Hims & Hers Health Inc (NYSE:HIMS) shares changed hands as the company’s beta touched 1.61. With the company’s most recent per share price at $33.54 changing hands around $0.4 or 1.21% at last look, the market valuation stands at $7.45B. HIMS’s current price is a discount, trading about -117.59% off its 52-week high of $72.98. The share price had its 52-week low at $11.20, which suggests the last value was 66.61% up since then. When we look at Hims & Hers Health Inc’s average trading volume, we note the 10-day average is 23.75 million shares, with the 3-month average coming to 20.83 million.
Analysts gave the Hims & Hers Health Inc (HIMS) stock a consensus recommendation rating of Buy, calculated at a mean rating of 2.47. If we narrow down to specifics, the data shows that 0 out of 13 analysts rate the stock as a Sell, with a further 1 assigning it an Overweight rating. Of the remaining, 5 recommended HIMS as a Hold, 7 felt it is a Buy and 0 rated the stock as Underweight.
Hims & Hers Health Inc (NYSE:HIMS) trade information
Instantly HIMS is in green as seen in intraday trades today. With action -2.70%, the performance over the past five days has been red. The company’s shares are showing year-to-date upside of 38.71%, with the 5-day performance at -2.70% in the red. However, in the 30-day time frame, Hims & Hers Health Inc (NYSE:HIMS) is -43.33% down. Looking at the short shares, we see there were 51.84 million shares sold at short interest cover period of 1.68 days.
The consensus price target for the stock as assigned by Wall Street analysts is 25.5, meaning bulls need a downside of -31.53% from its recent market value. According to analyst projections, HIMS’s forecast low is 21 with 68 as the target high. To hit the forecast high, the stock’s price needs a -102.74% plunge from its current level, while the stock would need to tank 37.39% for it to hit the projected low.
Hims & Hers Health Inc (HIMS) estimates and forecasts
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 17.22%. The 2025 estimates are for Hims & Hers Health Inc earnings to increase by 12.05%, but the outlook for the next 5-year period is at 31.05% per year.
Hims & Hers Health Inc (NYSE:HIMS)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 11.25% of Hims & Hers Health Inc shares while 79.06% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 89.08%. There are 79.06% institutions holding the Hims & Hers Health Inc stock share, with VANGUARD GROUP INC the top institutional holder. As of 2024-06-30, the company held 7.7166% of the shares, roughly 16.47 million HIMS shares worth $332.55 million.
BLACKROCK INC. holds the second largest percentage of outstanding shares, with 6.8278% or 14.57 million shares worth $294.25 million as of 2024-06-30.
Among Mutual Funds, the top two as of Jan 31, 2025 were iShares Core S&P Smallcap ETF and Vanguard Total Stock Market Index Fund. With 12.29 shares estimated at $406.39 million under it, the former controlled 5.75% of total outstanding shares. On the other hand, Vanguard Total Stock Market Index Fund held about 2.47% of the shares, roughly 5.27 shares worth around $174.39 million.
